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1. Introduction 
Sudden cardiac deaths remain the major cause of mortality in the western world. 
Ventricular arrhythmia due to ischemic heart disease is the most frequent cause of sudden 
cardiac death. In patients >35 years of age, ischemic heart disease is the most frequent cause 
of ventricular arrhythmias. In patients <35 years of age, inherited cardiac diseases play a 
significant role in sudden cardiac death. Prediction of who will experience a life-threatening 
ventricular arrhythmia is a major challenge in current cardiology. 
An implantable cardioverter defibrillator (ICD) provides efficient preventive treatment for 
ventricular arrhythmias and sudden death and is implanted in patients at risk. However, 
risk stratification of ventricular arrhythmias is insufficient and the majority of patients dying 
suddenly have not been evaluated for ICD therapy. 
Patients after myocardial infarction are at high risk for cardiac arrhythmic events and sudden 
cardiac death (Zipes, 2006). Currently, LV ejection fraction (EF) is the primary parameter used 
to select patients for ICD therapy after a myocardial infarction. Impaired EF is shown to be a 
marker of increased cardiovascular mortality and sudden cardiac death. However, EF has 
relatively low sensitivity to detect arrhythmic risk (Buxton, 2007). A number of other 
diagnostic tests have been proposed to improve the accuracy for selection of patients for ICD 
therapy. Currently available data, however, are not adequate to routinely recommend 
additional risk-stratification methods for selection of patients for ICD therapy (Passman, 2007).  
The presence of myocardial scar forms the substrate for malignant arrhythmias (Zipes, 
1998). Heterogeneity in scar tissue may create areas of slow conduction that generate the 
substrate for ventricular arrhythmia post-myocardial infarction (Verma, 2005). Electrical 
dispersion, including both activation time and refractoriness, in infarcted tissue is a known 
arrhythmogenic factor, (Endresen, 1987; Han, 1964; Janse, 1989; Vassallo, 1988). Electrical 
abnormalities may lead to distorted myocardial function (Nagueh, 2008). Therefore, regional 
differences in electrical properties may cause heterogeneity of myocardial contraction which 
can be recognized as myocardial dyssynchrony (Yu, 2003).  
In this report, a novel echocardiographic method will be presented in order to evaluate the 
cardiac contractility pattern in patients at increased risk of life-threatening arrhythmias.  
2. Modern echocardiographic modalities  
Better echocardiographic tools for more accurate assessment of ventricular function have 
been developed during the last 2 decades. Minor degrees of myocardial contraction 
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heterogeneity and contraction dyssynchrony can be demonstrated by these modern 
echocardiographic techniques (Reisner, 2004; Yu, 2007). One way to discover subtle wall 
motion abnormalities caused by electrical heterogeneity would be to use strain 
echocardiography (Edvardsen, 2002b). The introduction of strain echocardiography has 
made it possible to accurately perform quantitative and objective measures of regional 
ventricular function by measuring regional contraction by strain. Strain can accurately 
quantify timing and deformation of regional myocardial function (Edvardsen, 2002a; 
Reisner, 2004; Voigt, 2003). 
Currently, visual assessment of regional myocardial function from 2-D image is the 
standard echocardiographic method to assess ventricular function in daily clinical practice. 
Visual assessment has had that position since the introduction of 2-D echocardiography. 
This method has also been established as a clinically important tool in detecting regional 
ventricular function, but has limited ability to detect more subtle changes in function and 
changes in timing of myocardial motion throughout systole and diastole. Strain 
echocardiographic technique may be used to accurately assess timing and function of 
myocardial contraction in patients with increased risk of ventricular arrhythmias. The 
hypotheses that echocardiography can contribute to arrhythmic risk assessment is based on 
the assumption that arrhythmogenic electrical abnormalities will lead to mechanical 
alterations which can be assessed by strain echocardiography. 
2.1 Use of strain echocardiography for prediction of ventricular arrhythmias 
We have recently reported that strain echocardiography can be used as a novel risk 
predictor of ventricular arrhythmias in patients with the long QT syndrome (Haugaa, 2009; 
Haugaa, 2010a). The long QT syndrome has traditionally been regarded as a purely 
electrical disease. Sporadic reports have indicated, however, that the electrical alterations 
may lead to mechanical consequences (De Ferrari, 2009; Nador, 1991). In our publications, 
we could show by modern echocardiographic techniques that subtle contraction 
heterogeneity was present in patients with the long QT syndrome, possibly due to electrical 
abnormalities. Therefore, these echocardiographic techniques were able to detect subtle 
changes in myocardial function. Furthermore, we could associate mechanical dispersion to 
ventricular arrhythmias in patients with arrhythmogenic right ventricular cardiomyopathy 
(Sarvari, 2011). Contraction heterogeneity defined as mechanical dispersion was a marker of 
arrhythmias in these patients and could help risk stratification of arrhythmias in so far 
asymptomatic mutation carriers. In a recent paper, we investigated if contraction 
heterogeneity due to fibrosis in infarcted myocardial tissue leads to mechanical dispersion 
in patients after myocardial infarction (Haugaa, 2010b). These results are briefly presented 
below. We presumed that the mechanical dispersion reflected electrical heterogeneity. We 
investigated if mechanical dispersion can predict ventricular arrhythmias in patients with 
risk of ventricular arrhythmias. Furthermore, we investigated if global strain by 
echocardiography is a better marker of arrhythmias than EF in patients after myocardial 
infarction.  
3. Study of 85 post MI patients with an ICD 
We prospectively investigated 85 post-MI patients fulfilling indications for ICD therapy. All 
patients had prior myocardial infarction and indication for ICD therapy according to 
primary or secondary prevention criteria. Arrhythmic events, defined as ventricular 
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arrhythmias that required appropriate anti tachycardia pacing or shock from the ICD, were 
recorded. During 2.3 years of follow up, 45% of the ICD patients experienced one or more 
episodes with sustained ventricular tachycardia or ventricular fibrillation requiring 
appropriate ICD therapy (anti tachycardia pacing or shock) while 55% had no sustained 
arrhythmia during follow up.  
Speckle tracking technique by strain echocardiography was used to assess the contraction 
duration in each of the 16 left ventricular segments (Figure 1). Mechanical dispersion was 
calculated as the standard deviation from contraction durations the 16 left ventricular 
segments. Global left ventricular strain was obtained by averaging all segmental values for 
maximum shortening in a 16 segment model.  
 
 
Fig. 1. Speckle tracking longitudinal strain curves from 6 segments in apical 4 chamber view 
from a healthy individual with synchronous ECG recording below. Segment contraction 
(shortening) starts during QRS and reaches a maximum myocardial shortening (white 
vertical arrow) at the end of the ECG T-wave. (Modified from JACC Cardiovasc Imaging 2010 
March;3(3):247-56). 
The study showed that mechanical dispersion was significantly more pronounced in those 
with arrhythmias compared to those without (Fig 2). Furthermore, mechanical dispersion 
was a strong and independent predictor of arrhythmias requiring ICD therapy. 
Survival analyses showed that ICD patients with mechanical dispersion > 70ms showed 
more frequent arrhythmic events than ICD patients with dispersion < 70ms (Fig 3).  
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Fig. 2. Strain curves from a healthy individual (left panel), a post MI patient with 
arrhythmias (mid panel) and a post MI patient with recurrent arrhythmias (right panel). 
White arrows indicate timing of maximum myocardial shortening. The post MI patient with 
recurrent arrhythmias (right panel) has the most dispersed timing in myocardial contraction 
and thereby most pronounced mechanical dispersion. (Modified from JACC Cardiovasc 
Imaging 2010 March;3(3):247-56). 
 
 
Fig. 3. Kaplan Meier analyses of 85 patients after myocardial infarction with ICD. 
Patients with mechanical dispersion > 70 ms have higher rate of arrhythmic events during 
follow up compared to patients with mechanical dispersion < 70 ms. (Modified from JACC 
Cardiovasc Imaging 2010 March;3(3):247-56). 
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In ICD patients with EF > 35%, mechanical dispersion was more pronounced in those who 
experienced arrhythmia compared to those without. Global strain showed better left 
ventricular function in those without recorded arrhythmias, while EF did not differ. 
The results of the study showed that increased heterogeneity of myocardial contraction 
measured by strain echocardiography predicted cardiac arrhythmias better than current risk 
stratification tools. This novel method may improve risk stratification of cardiac arrhythmias 
and help the clinician to select patients for ICD therapy. 
4. Electromechanical interactions 
There is ample evidence from different cardiac disease models, including heart failure 
(Tomaselli, 2004), ischemia (Han, 1964)  and infarction (Spragg, 2005; Vassallo, 1988) that 
increases in dispersion of conduction velocity result in susceptibility to arrhythmias (Spragg, 
2005; Tomaselli, 2004). These electrical abnormalities will presumptively lead to changes in 
myocardial function. Assessing the extent of electrical dispersion in the individual patient 
has so far been difficult (Tomaselli, 2004). These findings support the idea that tissue 
heterogeneity in and around scarred myocardium lead to a dispersed myocardial 
contraction and is associated with risk of arrhythmic events.  
Earlier echocardiographic studies have observed that an EF of 40% serves as the threshold 
for identifying high-risk individuals (Bigger, Jr., 1984; Greenberg, 1984). However, EF has 
reduced sensitivity in predicting sudden death (Buxton, 2007; Stecker, 2006). Speckle based 
strain has shown to be a robust technique for assessment of LV function and a recent study 
has demonstrated that speckle tracking strain is superior to EF for assessment of myocardial 
function post-myocardial infarction (Gjesdal, 2008). Global strain discriminated between 
those with and without arrhythmic events in post-MI patients with EF > 35%. This finding 
suggests that global strain might become a useful tool for risk stratification in post-
myocardial infarction patients with relatively preserved LV function. Future trials should 
investigate if mechanical dispersion and global strain can be used to select additional 
patients for ICD therapy among the majority of patients after myocardial infarction with 
relatively preserved EF in whom current ICD indications fail. 
5. Risk assessment of ventricular arrhythmias in patients with 
arrhythmogenic right ventricular cardiomyopathy 
Arrhythmogenic right ventricular cardiomyopathy is an inheritable, chronic and 
progressive cardiomyopathy and is one of the leading causes of sudden unexpected cardiac 
death in previously healthy young individuals (Sen-Chowdhry, 2010a; Thiene, 1988). 
Prevalence has been estimated to be at least 1 in 1000 (Sen-Chowdhry, 2010a). 
Recent molecular genetic reports have revealed arrhythmogenic right ventricular 
cardiomyopathy as mainly a desmosomal disease (Xu, 2010). Mutations in one of the 5 
desmosomal or 3 extra desmosomal genes so far identified, lead to progressive loss of 
myocytes, followed by fibro-fatty replacement. Penetrance is age and gender dependent and 
the progressive clinical picture is highly variable (Dalal, 2006).  
Four clinical stages have been documented: An early concealed phase, overt electrical 
disorder, isolated right heart failure (Fig 4a), and biventricular pump failure (Fig 4b) (Basso, 
1996; Sen-Chowdhry, 2007; Sen-Chowdhry, 2010a). Importantly, life-threatening 
arrhythmias can occur with only discrete or even absent myocardial structural changes (Sen-
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Chowdhry, 2010b). Risk stratification of ventricular arrhythmias and sudden cardiac death 
is therefore challenging.  
 
 
Fig. 4. Echocardiographic pictures of 2 patients with arrhythmogenic right ventricular 
cardiomyopathy. 
A) left panel: classical right sided affection with dilatation (5 cm diameter, white arrow) and 
wall thinning of the right ventricle. The ICD lead is visible in the right ventricle.  
B) right panel: Affection of both right and left ventricle in a patient with arrhythmogenic 
right ventricular cardiomyopathy. The right ventricle is dilated and with visible ICD lead. 
Furthermore, the left ventricle is dilated and shows apical affection of the myocardial wall 
(arrow).  
Mechanisms of arrhythmias in early stages of arrhythmogenic right ventricular 
cardiomyopathy are probably due  to dysfunction of desmosomal proteins and disturbed 
cell to cell coupling (Saffitz, 2009). In later stages of arrhythmogenic right ventricular 
cardiomyopathy when structural abnormalities in the myocardium have developed, 
reentrant ventricular arrhythmias can occur in tissue with fibro fatty replacement. Therefore, 
electrical conduction delay with consequent electrical dispersion has been suggested as an 
important mechanism of ventricular arrhythmias (Amlie, 1997; Turrini, 2001). 
In a recent study we investigated if arrhythmogenic right ventricular cardiomyopathy 
patients had cardiac contraction heterogeneity assessed as mechanical dispersion and if 
contraction heterogeneity was associated with susceptibility to ventricular arrhythmias 
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(Sarvari, 2011). Furthermore, we investigated if mechanical dispersion was present in 
arrhythmogenic right ventricular cardiomyopathy mutation carriers in early stages of the 
disease where no structural alterations were visible.  
Mechanical dispersion and strain in right and left ventricle were assessed in 36 
arrhythmogenic right ventricular cardiomyopathy patients, in 23 asymptomatic 
arrhythmogenic right ventricular cardiomyopathy mutation carriers and in 30 healthy 
individuals. All 36 arrhythmogenic right ventricular cardiomyopathy patients had 
experienced ventricular arrhythmias either as aborted cardiac arrest or as documented 
sustained ventricular tachycardia and fulfilled 2010 International Task Force criteria 
(Marcus, 2010). They were treated with ICD in addition to medical anti arrhythmic therapy. 
The 23 asymptomatic mutation carriers were family members of the arrhythmogenic right 
ventricular cardiomyopathy patients and were diagnosed by cascade genetic screening. 
Peak systolic myocardial strain by 2D speckle tracking echocardiography was assessed in 16 
left ventricular segments and averaged to left ventricular global longitudinal strain in 
arrhythmogenic right ventricular cardiomyopathy patients. Additionally, peak systolic 
strain from 3 right ventricular free wall segments was averaged as a measure of right 
ventricular function (RV strain) (Fig 5). Contraction duration was measured as time from 
onset R on ECG to maximum LV and right ventricular shortening by strain. Standard 
deviation of contraction duration was calculated as mechanical dispersion, in a 16 left 
ventricular segments and a 6 right ventricular segments model.  
 
 
Fig. 5. Strain curves in an patient with arrhythmogenic right ventricular cardiomyopathy. 
Strain curves from a dilated right ventricle from apical 4 chamber view. Vertical arrows 
indicate the timing of maximum myocardial shortening in each right ventricular segment 
and are consistent with pronounced right ventricular mechanical dispersion.  
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Mechanical dispersion was more pronounced in arrhythmogenic right ventricular 
cardiomyopathy patients with arrhythmias in right and left ventricle compared to 
asymptomatic mutation carriers and healthy individuals (Table 1). Importantly, 
mechanical dispersion was more pronounced in asymptomatic mutation carriers 
compared to healthy individuals in both right and left ventricle, indicating sub clinical 
ventricular involvement. Right and left ventricular strains were reduced in 
arrhythmogenic right ventricular cardiomyopathy patients compared to asymptomatic 
mutation carriers and healthy individuals (Table 1). Reduced right and left ventricular 
strains were significantly correlated in arrhythmogenic right ventricular cardiomyopathy 
patients, indicating biventricular disease. Right and left ventricular function in 
asymptomatic mutation carriers were within normal range, but significantly reduced 













EF (%) 64±5 63±4 57±14* <0.01 
LV strain (%) -23±2 -20±2* -16±5*·** <0.001 
RV strain (%) -28±5 -24±5* -19±7*·** <0.001 
LV Dispersion 
(ms) 
22±8 42±13* 64±25*·** <0.001 
RV Dispersion 
(ms) 
15±8 33±20* 53±25*·** <0.001 
Table 1. Echocardiographic results in 36 ARVC patients, 23 asymptomatic ARVC mutation 
carriers and 30 healthy individuals. 
Mean±SD. Right column shows P-values for ANOVA test. Flags for significance are 
obtained from the post hoc pair-wise comparison using the Bonferroni correction. *p<0.05 
compared with healthy individuals. **p<0.01 compared with asymptomatic mutation 
carriers. ANOVA, analysis of variance; EF, ejection fraction; RV, right ventricular; LV, left 
ventricular.  
Risk stratification of ventricular arrhythmias in so far asymptomatic arrhythmogenic right 
ventricular cardiomyopathy mutation carriers is difficult. This report demonstrated that 
mechanical dispersion was closely related to ventricular arrhythmias in patients with 
arrhythmogenic right ventricular cardiomyopathy. Increased mechanical dispersion in 
both ventricles was present in asymptomatic mutation carriers, indicating sub clinical 
myocardial alterations. Importantly, pronounced mechanical dispersion was also present 
in individuals who had experienced arrhythmias in the early stages of arrhythmogenic 
right ventricular cardiomyopathy and in whom no structural alterations assessed by 
conventional echocardiography and magnetic resonance imaging could be assessed. These 
findings suggest that mechanical dispersion may be a marker of arrhythmic events and 
help risk stratification in so far asymptomatic arrhythmogenic right ventricular 
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cardiomyopathy mutation carriers. Mechanical dispersion and myocardial strains 
demonstrated subclinical myocardial involvement in these individuals. Longitudinal 
follow up studies are required to assess if these methods can provide added value in 
arrhythmia risk stratification in asymptomatic arrhythmogenic right ventricular 
cardiomyopathy mutation carriers.  
Furthermore, this paper demonstrated frequent and early left ventricular involvement in 
arrhythmogenic right ventricular cardiomyopathy which supported recent reports of 
arrhythmogenic right ventricular cardiomyopathy as a biventricular disease (Kjaergaard, 
2007).  Biventricular impairment is probably a result of biventricular arrhythmogenic right 
ventricular cardiomyopathy affection, but mutual dependency of right and left ventricular 
hemodynamics may be considered. In patients with overt arrhythmogenic right ventricular 
cardiomyopathy, strain echocardiography may be a useful tool for quantification of right 
and left sided myocardial dysfunction.  
6. Comparisons of mechanical dispersion in patients after myocardial 
infarction and in patients with arrhythmogenic right ventricular 
cardiomyopathy 
Mechanical dispersion has been demonstrated in arrhythmogenic right ventricular 
cardiomyopathy patients and in post-myocardial infarction patients and has been shown to 
be a marker of recurrent ventricular arrhythmias in both conditions. The mechanisms for 
arrhythmias in arrhythmogenic right ventricular cardiomyopathy and in infarcted 
myocardial tissue are different, but have similarities regarding electrical dispersion. In 
arrhythmogenic right ventricular cardiomyopathy patients, mechanisms of arrhythmias are 
probably stage dependent, but electrical dispersion has been considered to be of importance 
in early and later stages of the disease (Amlie, 1997; Turrini, 2001). In post-MI patients 
delayed start of ventricular activation in scarred myocardium leads to a dispersed recovery 
of excitability (Vassallo, 1988), finally resulting in dispersed electrical repolarization. One 
might therefore speculate that electrical dispersion may be regarded as the final common 
pathway of arrhythmia mechanism in both conditions.  
The extent of mechanical dispersion appeared most pronounced in post-myocardial 
infarction patients. This difference was probably a result of the concomitant contractile 
impairment in infarcted tissue which was more pronounced compared to presence of 
fibrosis in arrhythmogenic right ventricular cardiomyopathy. Myocardial function was 
significantly impaired in post-myocardial infarction patients compared to arrhythmogenic 
right ventricular cardiomyopathy patients. Contractile impairment will pronounce 
mechanical dispersion. The ranges and values of mechanical dispersion which are related to 
increased arrhythmic risk will therefore not necessarily be interchangeable between 
different myocardial diseases.  
7. Future risk assessment of ventricular arrhythmias and additional patient 
entities  
The most important patient group for further risk assessment of ventricular arrhythmias are 
patients after myocardial infarction representing the largest cohort of individuals at risk.  
Future trials should investigate if mechanical dispersion and global strain can be used to 
select additional patients for ICD therapy among the majority of post-myocardial infarction 
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patients with relatively preserved EF in whom current ICD indications fail. Furthermore, 
there are several large groups of patients who are at risk of ventricular arrhythmias on a 
non-ischemic basis, i.e. patients with idiopathic dilated cardiomyopathies, other 
cardiomyopathies and patients with congenital heart disease. It is of great concern that EF is 
currently the only parameter to select patients with idiopathic dilated cardiomyopathy for 
ICD therapy. There is emerging awareness of the insufficiency of EF to predict ventricular 
arrhythmias in these patients and further risk stratification tools are urgently needed. 
Mechanical dispersion may reflect the electrical dispersion and represent a fundamental 
arrhythmogenic factor. Furthermore, mechanical dispersion has been shown to predict 
arrhythmias independently of EF. Mechanical dispersion may therefore have the potential to 
be introduced as an additional tool in arrhythmic risk stratification in other groups of 
patients.  
8. Conclusion 
In summary, mechanical dispersion has been shown to predict ventricular arrhythmias in 
post-myocardial infarction patients and in patients with arrhythmogenic right ventricular 
cardiomyopathy and the long QT syndrome. This principle may therefore be a valuable 
supplement in evaluating patients at risk independently of EF.  Mechanical dispersion and 
global strain may be useful for including more patients for ICD therapy after myocardial 
infarction. 
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